Epidermal growth factor receptor antibody plus recombinant human endostatin in treatment of hepatic metastases after remnant gastric cancer resection.
作者： Long Sun , Huang-Yang Ye , Ying-Hong Zhang , Yong-Song Guan , Hua Wu
关键词:
摘要: We report a 55-year-old male who developed advanced hepatic metastasis and peritoneal carcinomatosis after resection of remnant gastric cancer 3 mo ago. The patient only received epidermal growth factor (EGF) receptor antibody (Cetuximab) plus recombinant human endostatin (Endostar). Anti-tumor activity was assessed by (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computer tomography (PET/CT) at baseline then every 4 wk. case illustrates that (18)FDG-PET/CT could make an early prediction the response to Cetuximab Endostar in such clinical situations. is useful molecular imaging modality evaluate biological patients resection.
sci-hub.st 参考文章(13)
JC Becker, C Müller-Tidow, H Serve, W Domschke, T Pohle, Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy. World Journal of Gastroenterology. ,vol. 12, pp. 3297- 3305 ,(2006) , 10.3748/WJG.V12.I21.3297
Qinghua Zhou, Ruihe Yang, Wu Zhuang, Donglin Wang, Xiaoqing Liu, Mei Hou, Xiuwen Wang, Yan Sun, Lifen You, Huishan Lu, Yanjun Zhang, Yunzhong Zhu, Jingmin Zhou, Houjie Liang, Hong Sun, Fengzhan Qin, Suxia Luo, Chen Yao, Jinwan Wang, Yiping Zhang, Zhongzhen Guan, Yuanrong Tu, Qitao Yu, Yongyu Liu, Shuping Song, Kai Li, Jiejun Wang, Weilian Li, Jing Wang, [Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients]. Chinese Journal of Lung Cancer. ,vol. 8, pp. 283- 290 ,(2005) , 10.3779/J.ISSN.1009-3419.2005.04.07
Keishiro Aoyagi, Kikuo Kouhuji, Shojiro Yano, Motoshi Miyagi, Takuya Imaizumi, Jinryo Takeda, Kazuo Shirouzu, VEGF significance in peritoneal recurrence from gastric cancer Gastric Cancer. ,vol. 8, pp. 155- 163 ,(2005) , 10.1007/S10120-005-0329-4
C. J. Shu, S. Guo, Y. J. Kim, S. M. Shelly, A. Nijagal, P. Ray, S. S. Gambhir, C. G. Radu, O. N. Witte, Visualization of a primary anti-tumor immune response by positron emission tomography Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 17412- 17417 ,(2005) , 10.1073/PNAS.0508698102
R. Weissleder, Molecular Imaging in Cancer Science. ,vol. 312, pp. 1168- 1171 ,(2006) , 10.1126/SCIENCE.1125949
Takuo Takehana, Kazuyoshi Kunitomo, Shioto Suzuki, Koji Kono, Hideki Fujii, Yoshiro Matsumoto, Akishi Ooi, Expression of epidermal growth factor receptor in gastric carcinomas Clinical Gastroenterology and Hepatology. ,vol. 1, pp. 438- 445 ,(2003) , 10.1016/S1542-3565(03)00219-2
John G Shelton, Linda S Steelman, Steve L Abrams, Fred E Bertrand, Richard A Franklin, Martin McMahon, James A McCubrey, The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: what’s genetics got to do with it? Expert Opinion on Therapeutic Targets. ,vol. 9, pp. 1009- 1030 ,(2005) , 10.1517/14728222.9.5.1009
John M. Hoffman, Sanjiv S. Gambhir, Molecular Imaging: The Vision and Opportunity for Radiology in the Future Radiology. ,vol. 244, pp. 39- 47 ,(2007) , 10.1148/RADIOL.2441060773
Josep Tabernero, The role of VEGF and EGFR inhibition : Implications for combining anti-VEGF and anti-EGFR agents Molecular Cancer Research. ,vol. 5, pp. 203- 220 ,(2007) , 10.1158/1541-7786.MCR-06-0404
Robert J. Gillies, Noninvasive imaging of anticancer therapy. Molecular Cancer Therapeutics. ,vol. 2, pp. 333- 334 ,(2003)